Health
Researchers to test monoclonal antibodies against COVID-19 – Mirage News
Getty Images “We need a treatment that is effective,” said infectious disease physician Ann Collier, who is leading the trial at UW Medicine. UW…
UW Medicine is one of a network of U.S. sites testing a new treatment for COVID-19 that involves monoclonal antibodies, which are intended to provide immediate antiviral activity that lasts several weeks.
The drug is part of the ACTIV-2 Outpatient Monoclonal Antibodies and Other Therapies Trial, sponsored by the National Institute of Allergy and Infectious Diseases. The trial is also receiving support from Operation Warp Speed, the U.S. government’s multi-agency effort to help end the pandemic….
-
Noosa News17 hours agoBondi Beach terror attack: Police investigate threat against Westfield North Lakes in Queensland
-
General17 hours agoGold, iron ore and population swell big state’s coffers
-
General17 hours agoPALM farm worker sentenced to eight years’ jail for raping teenager near Arrawarra
-
Noosa News18 hours agoNon-compliance, human error led to $2m Noosa Council fraud